Sustainability of costs of novel biologicals: Are we all heading for bankruptcy?
نویسندگان
چکیده
منابع مشابه
horizons of psychiatric genetics and epigenetics: where are we and where are we heading?
today multinational studies using genome-wide association scan (gwas) for >1000,000 polymorphisms on >100,000 cases with major psychiatric diseases versus controls, combined with next-generation sequencing have found ~100 genetic polymorphisms associated with schizophrenia (scz), bipolar disorder (bd), autism, attention deficit and hyperactivity disorder (adhd), etc. however, the effect size of...
متن کاملNutrition of Malaysians: where are we heading ?
Rapid and marked socioeconomic advancements in Malaysia for the past two decades have brought about significant changes in the lifestyles of communities. These include significant changes in the dietary patterns of Malaysians, eg the increase in consumption of fats and oils and refined carbohydrates and a decreased intake of complex carbohydrates. This resulted in a decline in the proportion of...
متن کاملWe are all stakeholders : Participatory decision - making and corporate sustainability
This paper is about extending stakeholder dialogue to include citizens in decision making which impacts on corporate sustainabilityolicy frameworks using the tools of regulation and economic instruments, and communication strategies, have a significant influence on the level of corporate sustainability. Involving citizens, through the use of deliberative and representative (participatory) proce...
متن کاملAmyloidosis-where are we now and where are we heading?
CONTEXT Amyloidoses are disorders of diverse etiology in which deposits of abnormally folded proteins share distinctive staining properties and fibrillar ultrastructural appearance. Amyloidosis ultimately leads to destruction of tissues and progressive disease. With recent advances in the treatment of systemic amyloidoses the importance of an early diagnosis of amyloid, and a correct diagnosis ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Clinical Pharmacology
سال: 2020
ISSN: 0306-5251,1365-2125
DOI: 10.1111/bcp.14295